NCT07446465 2026-03-03
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
Fudan University
Phase 4 Not yet recruiting
Clinical Trials
12 trialsNCT06090994 2025-05-07
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
Fudan University
Phase 4 Recruiting
NCT01468623 2023-07-19
PROFUSE
Myriad Genetic Laboratories, Inc.
Phase 4 Terminated
NCT02015923 2021-03-16
CCRe-IV
Hospital Universitari de Bellvitge
Phase 4 Terminated
NCT03518502 2018-05-08
Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis
Korea University
Phase 4 Unknown
NCT01770431 2017-10-02
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy
Qidong Gaitianli Medicines Co., Ltd
Phase 4 Completed
NCT00764621 2014-11-04
Health Economic Evaluation of Primovist-enhanced Liver MRI
Bayer
Phase 4 Completed
NCT02000739 2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4 Withdrawn
NCT01972503 2013-12-11
Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer
Fudan University
Phase 4 Unknown
NCT01894828 2013-07-10
Nutritional Supplementation in Patients With no Signs of Malnutrition
MedSource Polska
Phase 4 Unknown
NCT01564810 2012-10-24
Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer
Fudan University
Phase 4 Unknown
NCT00327093 2009-02-09
Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
Hospices Civils de Lyon
Phase 4 Terminated